논문 상세보기
본 연구에서는 배양 체계(혈청 첨가 TCM199, TALP, CRlaa 및 혈청 미첨가; IVMD101, IVF100, IVMD101)가 체외수정 또는 미세주입된 수정란의 체외 발달에 미치는 효과를 검토하였다. 또한 미세주입에 사용하는 GFP유전자의 양 및 미세주입 수정란에서 형광발현 양상을 검토하였다. 체외수정된 수정란의 ≥2세포기, 8세포기 및 배반포 도달율이 미세주입 수정란에 비하여 유의하게 높았다. 혈청 미첨가 배지에서의 8세포기 발달율이 수정란의 종류에 관계없이 유의하게 높았으나(p<0.05; 3.3% vs. 15.5% 및 21.4% vs. 39.4%, respectively), 배반포 도달율은 유사한 경향이었다(2.7% vs. 2.3% 및 23.0% vs. 23.6%, respectively). 한편, 2ng/uL 유전자를 미세주입한 수정란의 ≥2세포기, 8세포기 및 배반포 도달율이 4 및 8ng/uL의 것에 비하여 높은 경향이었다. 미세주입 수정란의 형광발현율은 1세포기가2및 8세포기에 비하여 유의하게 높았으나(p<0.05), 4세포기 및 배반포 단계와는 차이가 없었다.
This experiment was conducted to investigate effects of the two different in vitro production systems, serumcontaining system (IVM, IVF and IVC; TCM199, TALP and CR1aa) and serum-free system (IVM, IVF and IVC; IVMD101, IVMD100 and IVMD101), on the development of in vitro fertilized or DNA-microiniected embryos. We also examined the effect of DNA dosage and its expression pattern in embryos. The DNA used for microinjection was a green fluorescence protein gene. The development rates to ≥ 2cell, 8cell and blastocyst stage were significantly higher in vitro fertilized embryos than those in DNA-microinjected embryos. The development rate to the 8-cell stage was significantly higher in serum-free system than in serum-containing system (p<0.05; 3.3% vs.15.5% and 21.4%, respectively). The development rates to the blastocyst stage of in vitro fertilzed or DNA-microinjected embryos between two different culture system (2.7% vs. 2.3% and 23.0% vs. 23.6%, respectively) were not different. The development rates of embryos injected 2 ng/uL DNA was higher. than those of embryos injected 4 or 8 ng/uL DNA. The GFP expression rate of 1-cell embryos was significantly higher than that of 2-cell and 4-cell embryos, whereas the rates were not different between 4-cell and blastocyst-stage embryos.
